Cargando…
Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva
The COVID-19 pandemic has become an immense global health crisis. However, the lack of efficient and sensitive on-site testing methods limits early detection for timely isolation and intervention. Here, we present a Quantitative and Ultrasensitive in-situ Immunoassay Technology for SARS-CoV-2 detect...
Autores principales: | Chen, Yuchao, Roma, Gianluca, Liu, Fei, Lee, Luke P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814831/ https://www.ncbi.nlm.nih.gov/pubmed/33469572 http://dx.doi.org/10.21203/rs.3.rs-138025/v1 |
Ejemplares similares
-
Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva
por: Chen, Yuchao, et al.
Publicado: (2022) -
A fast, ultrasensitive SERS immunoassay to detect SARS-CoV-2 in saliva
por: Mohammadi, Moein, et al.
Publicado: (2022) -
Development of an Ultrasensitive Immunoassay for Detecting Tartrazine
por: Li, Zhuokun, et al.
Publicado: (2013) -
Ultrasensitive detection of SARS-CoV-2 spike protein in untreated saliva using SERS-based biosensor
por: Zhang, Meiling, et al.
Publicado: (2021) -
Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay
por: Sigal, George B., et al.
Publicado: (2021)